Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering

Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate

(2016) Alina Venereo-Sanchez et al.   VACCINE

Clinical Applications of Gene Therapy for Primary Immunodeficiencies

(2015) Maria Pia Cicalese et al.   HUMAN GENE THERAPY

Lentiviral vectors in cancer immunotherapy

(2015) Robyn AA Oldham et al.   Immunotherapy

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response

(2015) Katharina M. Uhlig et al.   JOURNAL OF VIROLOGY

Improved Cell-Penetrating Zinc-Finger Nuclease Proteins for Precision Genome Engineering

(2015) Jia Liu et al.   Molecular Therapy-Nucleic Acids

MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors

(2014) Dai-Tze Wu et al.   BIOMATERIALS

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA

(2014) S. Ramakrishna et al.   GENOME RESEARCH

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

(2014) John A Zuris et al.   NATURE BIOTECHNOLOGY

Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering

(2014) Jia Liu et al.   PLoS One

Technological Overview of iPS Induction from Human Adult Somatic Cells

(2013) Emilie Bayart et al.   CURRENT GENE THERAPY

Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium

(2013) Laura Cervera et al.   JOURNAL OF BIOTECHNOLOGY

Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells

(2013) Alejandro Negrete et al.   JOURNAL OF VIROLOGICAL METHODS

DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors

(2013) Yujia Cai et al.   NUCLEIC ACIDS RESEARCH

LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus

(2013) D. Finkelshtein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors

(2012) Hui Zhang et al.   BIOMATERIALS

The Choreography of HIV-1 Proteolytic Processing and Virion Assembly

(2012) Sook-Kyung Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors

(2012) Marc-André Robert et al.   JOURNAL OF GENE MEDICINE

HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component

(2012) L. Yang et al.   JOURNAL OF VIROLOGY

Regulation of KLF4 Turnover Reveals an Unexpected Tissue-Specific Role of pVHL in Tumorigenesis

(2012) Armin M. Gamper et al.   MOLECULAR CELL

HIV Gag polyprotein: processing and early viral particle assembly

(2012) Neil M. Bell et al.   TRENDS IN MICROBIOLOGY

Therapeutic potential of HIV protease-activable CASP3

(2012) Kosuke Miyauchi et al.   Scientific Reports

A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggyBac transposase

(2011) Cheng-Yi Lee et al.   BIOMATERIALS

Protein transduction domain delivery of therapeutic macromolecules

(2011) Arjen van den Berg et al.   CURRENT OPINION IN BIOTECHNOLOGY

Reprogramming of mouse and human somatic cells by high-performance engineered factors

(2011) Yang Wang et al.   EMBO REPORTS

Protein transduction by pseudotyped lentivirus-like nanoparticles

(2011) T Aoki et al.   GENE THERAPY

Efficient Protein Transduction Method Using Cationic Peptides and Lipids

(2011) Kei Yamaguchi et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Efficient Production of HIV-1 Virus-Like Particles from a Mammalian Expression Vector Requires the N-Terminal Capsid Domain

(2011) Pascal Jalaguier et al.   PLoS One

Protein delivery using engineered virus-like particles

(2011) S. J. Kaczmarczyk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55Gag

(2010) T Aoki et al.   GENE THERAPY

Endosomal escape pathways for delivery of biologicals

(2010) Amir K. Varkouhi et al.   JOURNAL OF CONTROLLED RELEASE

NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1

(2010) Thomas Güttler et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Protein transduction from retroviral Gag precursors

(2010) Christine Voelkel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

(2009) Dohoon Kim et al.   Cell Stem Cell

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins

(2009) Hongyan Zhou et al.   Cell Stem Cell

Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors

(2009) Robert H Kutner et al.   Nature Protocols

Three-Dimensional Analysis of Budding Sites and Released Virus Suggests a Revised Model for HIV-1 Morphogenesis

(2008) Lars-Anders Carlson et al.   Cell Host & Microbe

Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C- 1 pleckstrin homology domain results in infectious pseudovirion production

(2008) E. Urano et al.   JOURNAL OF GENERAL VIROLOGY

Assembly Properties of Human Immunodeficiency Virus Type 1 Gag-Leucine Zipper Chimeras: Implications for Retrovirus Assembly

(2008) R. M. Crist et al.   JOURNAL OF VIROLOGY

Inducible Packaging Cells for Large-scale Production of Lentiviral Vectors in Serum-free Suspension Culture

(2008) Sophie Broussau et al.   MOLECULAR THERAPY